Metagenomi Therapeutics Inc. (MGX) Live Share Price, Invest From India

Metagenomi Therapeutics Inc. Stock Performance

as on June 25, 2026 at 2:15 pm IST

Day's High
$1.20
Day's Price Range
$1.29
$1.20
7.50%
Upside
52 Week's Low
52 Week's High
$1.13
52-Week Price Range
$3.95
$1.20
5.83%
Downside
229.17%
Upside

Metagenomi Therapeutics Inc. share price movements today

Previous Close: $1.24
Open: $1.24
Volume: 282.8K
Day's Low - High: $1.20 - $1.29
52 Week Low - High: $1.13 - $3.95

Metagenomi Therapeutics Inc. Historical Returns

1 Month Return: -11.11 %
3 Month Return: -13.67 %
1 Year Return: -23.08 %
3 Year Return: 0 %
5 Year Return: 0 %

Metagenomi Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Metagenomi Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$46.7M

EPS (TTM)

-2.3375

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-87.5M

Revenue (TTM)

22.3M

Profit Margin

0.00%

Return On Equity TTM

-49.02%

Metagenomi Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Metagenomi Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Metagenomi Therapeutics Inc.	BUY	$46.7M	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$38.5B	67.66%	72.41	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$118.9B	144.52%	27.78	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$64.8B	13.24%	15.08	29.65%	0.58%

Stock Returns calculator for Metagenomi Therapeutics Inc. Stock including INR - Dollar returns

The Metagenomi Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Metagenomi Therapeutics Inc. investment value today

Current value as on today

₹84,729

Returns

-₹15,271

(-15.27%)

Returns from Metagenomi Therapeutics Inc. Stock

-₹23,077 (-23.08%)

Dollar Impact

₹7,806 (+7.81%)

Analyst Recommendation on Metagenomi Therapeutics Inc. Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Metagenomi Therapeutics Inc.. Average target price of $8

Metagenomi Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Metagenomi Therapeutics Inc..

What analysts predicted

85%UPSIDE

Target Price

Current Price

$1.2

Analyzed by

10 Analysts

Target

$8.00

Metagenomi Therapeutics Inc. target price $8, a slight upside of 85% compared to current price of $1.2. According to 10 analysts rating.

Indian Investors' Interest in Metagenomi Therapeutics Inc. Stock

Search interest for Metagenomi Therapeutics Inc. Stock has increased by 83% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 26, 2026 to June 25, 2026

Change:83% versus previous 30 day period

Metagenomi Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	12	11	20	11	9	4	8	8	3	1
Gross Profit	-12	-20	20	11	9	-21	-13	7	2	1
Operating Income	-20	-29	-16	-22	-20	-27	-20	-22	-24	-24
EBITDA	-15	-23	-11	-19	-23	-23	-18	-19	-21	-21
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	1	1	1	1	1	1	1	1	1	1
Income Before Tax	-16	-25	-12	-20	-24	-24	-19	-20	-22	-23
Income Tax Expense	2	-3	-2	-2	-1	0	0	0	0	0
Net Income	-19	-25	-10	-18	-23	-25	-19	-20	-22	-23
Net Profit Margin	-155.61%	-225.36%	-53.67%	-163.04%	-243.37%	-606.71%	-233.85%	-235.51%	-576.02%	-1847.68%

Metagenomi Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Total Revenue	0	17	44	52	25
Gross Profit	0	15	-49	52	19
Operating Income	-23	-44	-78	-88	-96
EBITDA	-20	-39	-56	-78	-82
Interest Expense	0	0	-	-	-
Depreciation	0	1	4	5	5
Income Before Tax	-21	-41	-60	-83	-87
Income Tax Expense	0	2	8	-5	0
Net Income	-21	-43	-68	-78	-87
Net Profit Margin	-8823.87%	-253.45%	-152.50%	-149.26%	-348.54%

Metagenomi Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-25	-10	-18	-23	-25	-19	-20	-22	-23
Operating Cash Flow	-29	-26	-26	-26	-22	-21	-21	-23	-21
Investing Cash Flow	-94	-13	-8	28	24	19	27	32	3
Financing Cash Flow	86	-2	0	-	0	0	0	0	0
Change in Cash	-38	-41	-36	2	1	-2	5	8	-16

Metagenomi Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Net Income	-43	-68	-78	-87
Operating Cash Flow	29	-91	-109	-88
Investing Cash Flow	-122	45	-88	103
Financing Cash Flow	239	1	84	0
Change in Cash	147	-44	-113	14

Global Institutional Holdings in Metagenomi Therapeutics Inc.

Funds	Holdings
Vanguard Group Inc	3.37%
Vanguard Capital Management, LLC	2.81%
Renaissance Technologies Corp	2.09%
RBF LLC	0.17%
XTX Topco Ltd	0.18%

See all

Insights on Metagenomi Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 19.8% return, outperforming this stock by 42.9%
NEGATIVE IMPACT
Price Dip
In the last 1 month, MGX stock has moved down by -11.1%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 8.65M → 1.24M (in $), with an average decrease of 61.5% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 4 quarters, -19.90M → -23.05M (in $), with an average decrease of 5.1% per quarter

About Metagenomi Therapeutics Inc.

Metagenomi Therapeutics, Inc. an in vivo genome editing company, develops curative genetic medicines in the United States. The company's lead development program, MGX-001, is designed to provide curative, life-long protection from bleeding events and joint damage in adults and children with hemophilia. It has a collaboration agreement with Ionis Pharmaceuticals, Inc. for apolipoprotein C-III for the treatment of hyper triglyceridemia, transthyretin (TTR) for transthyretin amyloidosis, angiotensinogen (AGT) for refractory hypertension, and other programs. The company was formerly known as Metagenomi, Inc. and changed its name to Metagenomi Therapeutics, Inc. in January 2026. Metagenomi Therapeutics, Inc. was incorporated in 2016 and is headquartered in Emeryville, California.

Organisation	Metagenomi Therapeutics Inc.
Headquarters	5959 Horton Street, EmeryVille, CA, United States, 94608
Industry	Biotechnology
CEO	Dr. Jian Irish M.B.A., Ph.D.
E-voting on shares	Click here to vote

Key Management of Metagenomi Therapeutics Inc.

Name	Title
Mr. Matthew L. Wein J.D.	General Counsel, Compliance Officer, Head of BD&L and Corporate Secretary
Dr. Joseph Knowles M.D.	Co-Founder & Member of Scientific Advisory Board
Mr. Mark Leonard	Senior Vice President of Technical Development & Operations
Dr. Alan Brooks Ph.D.	Senior Vice President of Research
Ms. Katalin Kauser M.D., Ph.D.	Senior Vice President of Translational Biology
Dr. Jian Irish M.B.A., Ph.D.	CEO, President & Director
Dr. Brian Charles Thomas Ph.D.	Co-Founder & Director
Ms. Pamela M. Wapnick M.B.A.	Chief Financial Officer

FAQs

What is Metagenomi Therapeutics Inc. share price today?

Metagenomi Therapeutics Inc. share price today is $1.2 as on June 25, 2026 at 8:45 am IST at the close of the market. Metagenomi Therapeutics Inc. share today touched a day high of $1.29 and a low of $1.2.

What is the 52 week high and 52 week low for Metagenomi Therapeutics Inc. share?

Metagenomi Therapeutics Inc. share touched a 52 week high of $3.95 on October 16, 2025 and a 52 week low of $1.13 on June 17, 2026. Metagenomi Therapeutics Inc. stock price today i.e. June 25, 2026 at 8:45 am IST is closed at $1.2,which is 69.62% down from its 52 week high and 6.19% up from its 52 week low.

What is Metagenomi Therapeutics Inc.'s market capitalisation today?

Metagenomi Therapeutics Inc. market capitalisation is $0.00T as on June 25, 2026 at 8:45 am IST.

How to invest in Metagenomi Therapeutics Inc. Stock (MGX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Metagenomi Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Metagenomi Therapeutics Inc. Shares that will get you 1.2500 shares as per Metagenomi Therapeutics Inc. share price of $1.2 per share as on June 25, 2026 at 8:45 am IST.

What is the minimum amount required to buy Metagenomi Therapeutics Inc. Stock (MGX) from India?

Indian investors can start investing in Metagenomi Therapeutics Inc. (MGX) shares with as little as ₹94.665 or $1 (as of June 25, 2026 at 2:40 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹946.65 in Metagenomi Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on June 25, 2026 at 2:40 pm IST). Based on Metagenomi Therapeutics Inc. share’s latest price of $1.2 as on June 25, 2026 at 8:45 am IST, you will get 8.3333 shares of Metagenomi Therapeutics Inc.. Learn more about fractional shares .